Key facts
- Arsenale Bioyards’s last known valuation is $14.0M (Nov 2023).
- It has raised $24.7M; the latest was Seed Round ($10.4M) in Feb 2025.
- Notable investors include Plug and Play Tech Center, CDP Venture Capital (Rome), Acequia Capital, byFounders, Planet A — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Arsenale Bioyards
- ·The full record, as it builds
Funding rounds
No funding rounds for Arsenale Bioyards are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Arsenale Bioyards
Developer of an end-to-end hardware and software platform intended for bio-manufacturing. The company's platform spans various stages of the biomanufacturing process, ranging from lab to manufacturing scale, to allow scalable, low-cost production through nature co-design, enabling firms to reduce cost, time-to-market, and risks in creating bio-based products.
- Sector
- Healthcare
- HQ
- Venice, Italy
- Founded
- 2022
- Employees
- 33
- Website
- arsenale.bio/
- Ownership
- Privately Held (backing)
Arsenale Bioyards doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arsenale Bioyards shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arsenale Bioyards in its N-PORT filings yet. We sweep new filings monthly.